Predictive Oncology Inc.
POAI
$1.06
-$0.03-2.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.17M | -- | -3.18M | -4.22M | -3.48M |
| Total Depreciation and Amortization | 573.60K | -- | 164.20K | 162.60K | 517.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.00K | -- | 119.40K | -300.00 | 219.60K |
| Change in Net Operating Assets | -538.50K | -- | -320.40K | 640.50K | -344.50K |
| Cash from Operations | -2.15M | -- | -3.22M | -3.42M | -3.08M |
| Capital Expenditure | 0.00 | -- | -6.50K | -3.00K | 15.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -- | -- | -- | -8.20K |
| Cash from Investing | 0.00 | -- | -6.50K | -3.00K | 7.30K |
| Total Debt Issued | 0.00 | -- | 275.10K | -- | 0.00 |
| Total Debt Repaid | -195.80K | -- | -38.00K | -112.40K | -109.80K |
| Issuance of Common Stock | 0.00 | -- | 3.70M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -- | -573.80K | -- | -- |
| Cash from Financing | -195.80K | -- | 3.36M | -112.40K | -111.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.34M | -- | 134.50K | -3.53M | -3.19M |